ClassID:

94515

C07D239/78 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems; Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2

Sub-classes:
Recent Application in this class:
#1
20250263554
2025-08-21

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

#2
20240335445
2024-10-10

Compounds and Compositions for Treating Fibrosis

#3
20240092735
2024-03-21

COMPOUNDS AND METHODS FOR TREATING CANCER

#4
20230181588
2023-06-15

Compounds and Compositions for Treating Fibrosis

#5
20230150929
2023-05-18

SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1

#6
20220372004
2022-11-24

BROMODOMAIN INHIBITORS

#7
20220127248
2022-04-28

Preparation method for morpholinquinazoline compound and intermediates thereof

#8
20210276988
2021-09-09

4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections

#9
20210147359
2021-05-20

Compounds and methods for treating cancer

#10
20200390770
2020-12-17

Compounds and compositions for treating fibrosis

#11
20200010418
2020-01-09

Compounds and methods for treating cancer

#12
20190177332
2019-06-13

Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof

#13
20180265476
2018-09-20

Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof

#14
20180148410
2018-05-31

Compounds and methods for treating cancer

#15
20180130956
2018-05-10

Organic electroluminescent materials and devices

#16
20180127420
2018-05-10

Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof

#17
20180072678
2018-03-15

Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof

#18
20170158644
2017-06-08

2-amino-5-keto-pyrimidine derivatives and the use thereof for controlling undesired plant growth

#19
20170035761
2017-02-09

Cytotoxic compounds which are inhibitors of the polymerisation of tubulin

#20
20160257673
2016-09-08

4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections

#21
20160243121
2016-08-25

Quinazoline derivatives, compositions, and uses related thereto

#22
20150216866
2015-08-06

Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors

#23
20130225596
2013-08-29

Heterocyclic derivative and pharmaceutical composition comprising the same

#24
20130066073
2013-03-14

Process for the preparation of dihydroquinazolines

#25
20120253041
2012-10-04

Phenylalanine derivatives

#26
20120130072
2012-05-24

Process for the preparation of dihydroquinazolines

#27
20120022054
2012-01-26

NOVEL SUBSTITUTED ARYL DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES AS ANTI-HIV AGENTS

#28
20110065918
2011-03-17

Phenylalanine derivatives

#29
20100247534
2010-09-30

Fused heterocyclic compounds as inhibitors of potassium channel function

#30
20090285782
2009-11-19

4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections

#31
20090221822
2009-09-03

Process for the preparation of dihydroquinazolines

#32
20070197527
2007-08-23

Bicyclic heteroaromatic compounds

#33
20060223836
2006-10-05

Phenylalanine derivatives

#34
20060178514
2006-08-10

Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors

#35
20050250783
2005-11-10

Quinazolinyl compounds as inhibitors of potassium channel function

#36
20050065166
2005-03-24

Substituted pyrimidines